Suppr超能文献

糠秕马拉色菌对唑类化合物的体外敏感性

In vitro susceptibility of Malassezia furfur against azole compounds.

作者信息

Schmidt A, Rühl-Hörster B

机构信息

Institut für Chemotherapie, Bayer AG, Wuppertal, FR Germany.

出版信息

Mycoses. 1996 Jul-Aug;39(7-8):309-12. doi: 10.1111/j.1439-0507.1996.tb00145.x.

Abstract

The minimum inhibitory concentrations (MICs) for 30 isolates of Malassezia furfur of four azole compounds-bifonazole, climbazole, clotrimazole and ketoconazole were determined as these substances are used in the topical therapy of M. furfur-associated skin conditions. M. furfur is a lipophilic fungus with complex growth requirements; the MICs were measured in a microdilution test system in modified Leeming-Notman medium by a colorimetric read-out with alamarBlue. The MICs of bifonazole ranged between < 0.06 and 1 microgram ml-1 with an empirical median of 0.06 microgram ml-1 for climbazole the MICs were < 0.06 to 0.5 microgram ml-1 (median < 0.06 microgram ml-1), for clotrimazole < 0.06 to 8 micrograms ml-1 (median 1 microgram ml-1), and for ketoconazole < 0.06 to 0.12 microgram ml-1 (median < 0.06 microgram ml-1). Climbazole and ketoconazole showed similar in vitro activity against M. furfur, with bifonazole having slightly lower, and clotrimazole the lowest in vitro activity. These findings may be explained by the extremely low water solubility of the last two compounds; the results have yet to be correlated with the in vivo efficacy of these substances.

摘要

由于四种唑类化合物(联苯苄唑、克霉唑、咪康唑和酮康唑)用于治疗与糠秕马拉色菌相关的皮肤疾病,因此测定了30株糠秕马拉色菌对这四种化合物的最低抑菌浓度(MIC)。糠秕马拉色菌是一种亲脂性真菌,生长要求复杂;在改良的Leeming-Notman培养基中,采用alamarBlue比色法在微量稀释试验系统中测定MIC。联苯苄唑的MIC范围在<0.06至1微克/毫升之间,克霉唑的经验中位数为0.06微克/毫升,咪康唑的MIC为<0.06至0.5微克/毫升(中位数<0.06微克/毫升),酮康唑的MIC为<0.06至0.12微克/毫升(中位数<0.06微克/毫升)。克霉唑和酮康唑对糠秕马拉色菌表现出相似的体外活性,联苯苄唑的体外活性略低,咪康唑的体外活性最低。后两种化合物极低的水溶性可能解释了这些结果;这些结果尚未与这些物质的体内疗效相关联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验